Citius Pharmaceuticals Inc (NASDAQ:CTXR)
| 2.10 Delayed Data As of Oct 15 |  -0.10 / -4.55%Today’s Change | 0.87 Today|||52-Week Range 4.56 | +105.88% Year-to-Date |
Latest CTXR News | Press Releases
No recent news for Citius Pharmaceuticals Inc.
Today’s Trading
| Previous close | 2.20 |
| Today’s open | 2.22 |
| Day’s range | 2.09 - 2.24 |
| Volume | 30,324 |
| Average volume (3 months) | 6,476,045 |
| Market cap | $305.1M |
Data as of 4:25pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | +41.96% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 3.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TXMDTherapeuticsMD Inc | -0.02 | -3.29% |
| VRNAVerona Pharma PLC | -0.03 | -0.60% |
| NLTXNeoleukin Therapeuti... | -0.15 | -2.04% |
| ATNXAthenex Inc | -0.12 | -4.14% |
Data as of 5:13pm ET, 10/15/2021
Financials
| Next reporting date | December 1, 2021 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$17.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cranford, New Jersey |
Forecasts
Chart unavailable
